1. Home
  2. JAGX vs FTFT Comparison

JAGX vs FTFT Comparison

Compare JAGX & FTFT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • JAGX
  • FTFT
  • Stock Information
  • Founded
  • JAGX 2013
  • FTFT N/A
  • Country
  • JAGX United States
  • FTFT United States
  • Employees
  • JAGX N/A
  • FTFT N/A
  • Industry
  • JAGX Biotechnology: Pharmaceutical Preparations
  • FTFT Business Services
  • Sector
  • JAGX Health Care
  • FTFT Consumer Discretionary
  • Exchange
  • JAGX Nasdaq
  • FTFT Nasdaq
  • Market Cap
  • JAGX 3.8M
  • FTFT 3.9M
  • IPO Year
  • JAGX N/A
  • FTFT N/A
  • Fundamental
  • Price
  • JAGX $8.06
  • FTFT $1.46
  • Analyst Decision
  • JAGX
  • FTFT
  • Analyst Count
  • JAGX 0
  • FTFT 0
  • Target Price
  • JAGX N/A
  • FTFT N/A
  • AVG Volume (30 Days)
  • JAGX 66.3K
  • FTFT 79.6K
  • Earning Date
  • JAGX 05-13-2025
  • FTFT 04-15-2025
  • Dividend Yield
  • JAGX N/A
  • FTFT N/A
  • EPS Growth
  • JAGX N/A
  • FTFT N/A
  • EPS
  • JAGX N/A
  • FTFT N/A
  • Revenue
  • JAGX $11,689,000.00
  • FTFT $2,158,125.00
  • Revenue This Year
  • JAGX $38.22
  • FTFT N/A
  • Revenue Next Year
  • JAGX $39.96
  • FTFT N/A
  • P/E Ratio
  • JAGX N/A
  • FTFT N/A
  • Revenue Growth
  • JAGX 19.75
  • FTFT N/A
  • 52 Week Low
  • JAGX $4.02
  • FTFT $1.15
  • 52 Week High
  • JAGX $540.00
  • FTFT $9.00
  • Technical
  • Relative Strength Index (RSI)
  • JAGX 57.58
  • FTFT 43.86
  • Support Level
  • JAGX $5.00
  • FTFT $1.28
  • Resistance Level
  • JAGX $6.13
  • FTFT $1.49
  • Average True Range (ATR)
  • JAGX 0.87
  • FTFT 0.19
  • MACD
  • JAGX 0.72
  • FTFT 0.04
  • Stochastic Oscillator
  • JAGX 88.07
  • FTFT 58.49

About JAGX Jaguar Health Inc.

Jaguar Health Inc is a commercial-stage pharmaceuticals company focused on developing novel, plant-based, non-opioid, and sustainably derived prescription medicines for people and animals with GI distress, specifically chronic, debilitating diarrhea. Its product Mytesi is a novel, first-in-class anti-secretory agent which has a basic normalizing effect locally on the gut, and this mechanism of action has the potential to benefit multiple disorders. It has two reportable segments namely human health and animal health. The company generates the majority of its revenue from the Human Health segment.

About FTFT Future FinTech Group Inc.

Future FinTech Group Inc is engaged in the financial technology business. The company participates in supply chain financing services and trading in China, asset management business in Hong Kong, and cross-border money transfer services in the United Kingdom. It has also expanded into brokerage and investment banking business in Hong Kong and cryptocurrency mining farm in the U.S. The company's reportable segments include the Supply chain financing/trading segment which generates key revenue, and the Asset management service segment.

Share on Social Networks: